Sinceru Florida L L C

FDA Filings

This page includes the latest FDA filings for Sinceru Florida L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1% Sinceru Florida, LLC, Sincerus Florida, LLC	Prescription Medication	2019-05-02
NDC 72934-2096 Sinceru Florida, LLC	HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%	2019-05-01

Similar & Related FDA Registered Companies

• Sincerus Florida, LLC